<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Larkin Josephsen | Activity</title>
	<link>https://www.catswannabecats.com/members/burstband0/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/burstband0/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Larkin Josephsen.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">de9620957d39c344d72dec6026995bd1</guid>
				<title>Larkin Josephsen posted an update: This study aimed to develop and validate a brief [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18030/</link>
				<pubDate>Tue, 03 Jun 2025 12:36:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>This study aimed to develop and validate a brief practitioner-friendly health literacy screening tool, called Rapid Estimate of Inadequate Health Literacy (REIHL), that estimates patients&#8217; health literacy inadequacy in demanding clinical settings.</p>
<p> This is a methodological study of 304 community-dwelling older adults recruited from one&hellip;<span class="activity-read-more" id="activity-read-more-18030"><a href="https://www.catswannabecats.com/activity/p/18030/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">90a3f16835e01e5748019dce434df097</guid>
				<title>Larkin Josephsen posted an update: i. -3·3 to -0·5) months per species; P=0·009). Adjuvant tr [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/15021/</link>
				<pubDate>Mon, 02 Jun 2025 11:42:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>i. -3·3 to -0·5) months per species; P=0·009). Adjuvant treatment with gemcitabine improved PFS in patients who were negative for K. <a href="https://www.selleckchem.com/products/dcemm1.html" rel="nofollow ugc">selleckchem</a> pneumoniae (26·2 versus 15·3 months; P =0·039), but not in those who tested positive (19·5 versus 13·2 months; P =0·137). Quinolone treatment was associated with improved median overall survival (OS) in&hellip;<span class="activity-read-more" id="activity-read-more-15021"><a href="https://www.catswannabecats.com/activity/p/15021/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f1e0ee4cf53efe35909e39876ee59923</guid>
				<title>Larkin Josephsen posted an update: n.Kv1.3 potassium channel is considered as a target for the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2174/</link>
				<pubDate>Sat, 31 May 2025 07:58:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>n.Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8+ T cells. However, the underlying signaling pathway related to autoimmune CD8+ T cell inhibition by Kv1.3 channel in neuroinflammatory&hellip;<span class="activity-read-more" id="activity-read-more-2174"><a href="https://www.catswannabecats.com/activity/p/2174/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">12f744cfa64c01933541d00b5c862046</guid>
				<title>Larkin Josephsen became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/1986/</link>
				<pubDate>Sat, 31 May 2025 07:44:08 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>